Earnings Ahead

CYDY - CytoDyn

CytoDyn

CytoDyn

About

Profile


Headquarters

Vancouver, Washington, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CYDY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • CytoDyn appoints Lalezari as its interim CEO
  • CytoDyn President Cyrus Arman takes medical leave
  • Former CytoDyn CEO Pourhassan charged with defrauding investors
  • CytoDyn voluntarily withdrawing BLA for HIV treatment leronlimab
  • CytoDyn hit by clinical holds on HIV and COVID-19 programs in the U.S.
  • Morgan Stanley projects about a third of biotechs will need financing in 2022
  • Long COVID, the next frontier for vaccine and drug developers
  • Short-term bounce for CytoDyn following CEO ousting not enough to stop slide
  • Ousting of CytoDyn CEO Pourhassan boosts stock; shares up 12%
  • CytoDyn announces change in leadership to support approval and commercialization of leronlimab
  • CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial
  • CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19
  • CytoDyn files for expanded access use of leronlimab for HIV patients
  • CytoDyn reports leronlimab data in NASH trial for first 15 patients
  • CytoDyn submits the first section of HIV BLA to FDA under rolling review
  • CytoDyn submits leronlimab Breakthrough Therapy designation application to the FDA
  • CytoDyn posts preliminary results from mid-stage leronlimab NASH study
  • CytoDyn treats first patient in late-stage leronlimab Brazil COVID-19 trial
  • CytoDyn says Court ruled activist group’s nominations were Invalid
  • CytoDyn announces legal actions against its former CRO, Amarex Clinical Research

Earnings History

Date EPS / Forecast Revenue / Forecast
July 28, 2021 -0.08 / -0.05 41.00K / - Beat!
April 28, 2021 -0.05 / -0.05 - / -
February 3, 2021 -0.06 / -0.05 - / -
October 28, 2020 -0.06 / -0.06 - / -
July 29, 2020 -0.12 / -0.05 - / 200K
April 29, 2020 -0.08 / -0.08 - / 1M
January 29, 2020 -0.04 / -0.04 - / 100K
October 30, 2019 -0.04 / -0.04 50K / 50K
July 31, 2019 -0.05 / -0.04 1.2M / - Beat!
May 1, 2019 -0.04 / -0.04 - / -
January 30, 2019 -0.06 / -0.05 - / -
October 31, 2018 -0.07 / -0.06 - / -
August 1, 2018 -0.05 / -0.07 - / -
May 2, 2018 -0.1 / -0.07 - / -
Date Price Open High Low Vol Change ER
Mar 11 0.4111 0.4139
0.4300
0.4000
1.28M -0.8%
Mar 10 0.4144 0.4300
0.4300
0.4010
2.00M 3.32%
Mar 9 0.4011 0.4500
0.4500
0.4011
1.97M -10.87%
Mar 8 0.4500 0.4351
0.4500
0.3945
2.80M -3.23%
Mar 7 0.4650 0.4847
0.4847
0.4300
1.74M -4.12%
 
Mar 4 0.4850 0.5000
0.5000
0.4800
639.89K 0%
Mar 3 0.4850 0.5050
0.5100
0.4750
2.28M 3.19%
Mar 2 0.4700 0.4750
0.4980
0.4650
1.15M -3.59%
Mar 1 0.4875 0.5190
0.5190
0.4810
1.06M -4.79%
Feb 28 0.5120 0.5143
0.5200
0.4800
2.17M 0.39%
Feb 25 0.5100 0.4500
0.5247
0.4400
2.70M 14.09%
Feb 24 0.4470 0.4910
0.5000
0.4310
3.75M -8.96%
Feb 23 0.4910 0.5000
0.5200
0.4750
1.62M 0.20%
Feb 22 0.4900 0.5400
0.5800
0.4800
2.32M -9.26%
Feb 18 0.5400 0.5650
0.6050
0.5300
2.56M -6.41%
Feb 17 0.5770 0.6000
0.6190
0.5600
1.44M -5.41%
Feb 16 0.6100 0.5900
0.6100
0.5700
974.11K 5.35%
Feb 15 0.5790 0.5700
0.5800
0.5300
1.29M 9.25%
Feb 14 0.5300 0.5710
0.5790
0.5210
1.14M -6.19%